Literature DB >> 22622129

A quantitative TR-FRET plate reader immunoassay for measuring autophagy.

Michael K Hancock1, Spencer B Hermanson, Nicholas J Dolman.   

Abstract

Autophagy involves the isolation and targeting of unwanted cellular components to lysosomes for their digestion and reuse. Autophagic dysregulation has recently been implicated in a wide range of disease processes, yet facile methods for quantifying autophagy have been lacking in the field. Here we describe the generation of a quantitative plate reader assay for measuring the autophagic activity of cells. One of the best characterized autophagy markers is the protein LC3B, which normally resides in the cytosol (LC3B-I) but upon induction of autophagy becomes lipidated and embedded in autophagosomal membranes (LC3B-II). To quantify autophagy, we reasoned that GFP-tagged LC3B could serve as a time-resolved fluorescence resonance energy transfer (TR-FRET) acceptor upon cell lysis in the presence of terbium-labeled LC3B antibodies. Using this TR-FRET immunoassay approach, we screened a panel of LC3B antibodies and identified an antibody that exhibits strong preferential affinity toward autophagosome-associated LC3B-II and thereby facilitates specific detection of autophagic activity. The plate reader format provides both a quantitative and an objective result, thus overcoming some of the key limitations of the traditional immunoblotting and imaging approaches used to monitor autophagy. Moreover, since the assay step requires only a single addition of cell lysis buffer containing the detection antibody its simple workflow is both automation-friendly and scalable, which renders it suitable for high-throughput screening. We demonstrate how this TR-FRET immunoassay for GFP-tagged LC3B-II can be applied to quantitatively detect changes in the autophagy activity of cells, including estimating effects on autophagic flux.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22622129     DOI: 10.4161/auto.20441

Source DB:  PubMed          Journal:  Autophagy        ISSN: 1554-8627            Impact factor:   16.016


  5 in total

1.  High throughput and miniaturised systems for biodegradability assessments.

Authors:  Mickael Cregut; Sulivan Jouanneau; François Brillet; Marie-José Durand; Cyril Sweetlove; Jean-Charles Chenèble; Jacques L'Haridon; Gérald Thouand
Journal:  Environ Sci Pollut Res Int       Date:  2013-10-26       Impact factor: 4.223

2.  DAMP production by human islets under low oxygen and nutrients in the presence or absence of an immunoisolating-capsule and necrostatin-1.

Authors:  Genaro A Paredes-Juarez; Neha M Sahasrabudhe; Reina S Tjoelker; Bart J de Haan; Marten A Engelse; Eelco J P de Koning; Marijke M Faas; Paul de Vos
Journal:  Sci Rep       Date:  2015-09-30       Impact factor: 4.379

3.  Suppression of MAPK11 or HIPK3 reduces mutant Huntingtin levels in Huntington's disease models.

Authors:  Meng Yu; Yuhua Fu; Yijiang Liang; Haikun Song; Yao Yao; Peng Wu; Yuwei Yao; Yuyin Pan; Xue Wen; Lixiang Ma; Saiyin Hexige; Yu Ding; Shouqing Luo; Boxun Lu
Journal:  Cell Res       Date:  2017-10-13       Impact factor: 25.617

4.  Quantifying autophagy using novel LC3B and p62 TR-FRET assays.

Authors:  Alberto Bresciani; Maria Carolina Spiezia; Roberto Boggio; Cristina Cariulo; Anja Nordheim; Roberta Altobelli; Kirsten Kuhlbrodt; Celia Dominguez; Ignacio Munoz-Sanjuan; John Wityak; Valentina Fodale; Deanna M Marchionini; Andreas Weiss
Journal:  PLoS One       Date:  2018-03-19       Impact factor: 3.240

5.  Targeting Gpr52 lowers mutant HTT levels and rescues Huntington's disease-associated phenotypes.

Authors:  Haikun Song; Hexuan Li; Shimeng Guo; Yuyin Pan; Yuhua Fu; Zijian Zhou; Zhaoyang Li; Xue Wen; Xiaoli Sun; Bingqing He; Haifeng Gu; Quan Zhao; Cen Wang; Ping An; Shouqing Luo; Youhong Hu; Xin Xie; Boxun Lu
Journal:  Brain       Date:  2018-06-01       Impact factor: 13.501

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.